4//SEC Filing
Greenstein Leonard M. 4
Accession 0001209191-23-017998
CIK 0001819790other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 7:24 PM ET
Size
7.9 KB
Accession
0001209191-23-017998
Insider Transaction Report
Form 4
Greenstein Leonard M.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-03-08+40,097→ 40,097 totalExercise: $15.00Exp: 2033-03-08→ Common Stock (40,097 underlying) - Award
Restricted Stock Units
2023-03-08+27,160→ 27,160 total→ Common Stock (27,160 underlying)
Footnotes (3)
- [F1]25% of the option shares shall vest on March 8, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001519692
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 7:24 PM ET
- Size
- 7.9 KB